EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical Outcomes of Candida auris Versus Other Candida Species Bloodstream Infections: An IPTW-Adjusted Cohort Study in South Korea

Mindong Sung iD, Shihwan Jang iD, Ah Young Leem iD, Chan Ho Lee iD, Kyung Soo Chung iD, Young Sam Kim iD, Joon Kim iD, Su Hwan Lee iD

Journal of Fungi · 06.07.2026 · 12 (7) · 495

DOI: 10.3390/jof12070495 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Fungi, online erschienen am 06.07.2026. Verfasst von Mindong Sung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 0…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Severance Hospital, Yonsei University College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida auris has emerged as a multidrug-resistant, healthcare-associated pathogen worldwide; however, outcome data on C. auris candidaemia in East Asia remain limited. We conducted a retrospective cohort study of adult patients with candidaemia who received antifungal therapy at a tertiary hospital in Seoul, Republic of Korea, from January 2023 to December 2024, comparing C. auris with other Candida species. Confounding was addressed by inverse probability of treatment weighting (IPTW) using a five-covariate propensity score (age, Charlson Comorbidity Index, septic shock, ICU admission at antifungal initiation, and concomitant Gram-negative infection). Among 423 patients, C. auris accounted for 6.9% of cases and was uniformly fluconazole non-susceptible, with frequent high-level caspofungin resistance but preserved micafungin and anidulafungin susceptibility. Patients with C. auris were older, with greater comorbidity and more frequent ICU admission at antifungal initiation. After IPTW adjustment, C. auris was not associated with higher 30-day mortality, the primary outcome (adjusted hazard ratio 0.59, 95% CI 0.26–1.32); the wide confidence interval indicates limited precision rather than equivalence, and results were directionally consistent for 90-day and in-hospital mortality and across sensitivity analyses that varied both the comparison cohort and the analytic method. Residual confounding by unmeasured illness severity and limited precision preclude concluding equivalence. Continued surveillance, molecular characterisation, and infection control remain essential.

Schlagwörter

Stichwörter der Autor:innen

Candida aurisEast Asiaantifungal susceptibilitybloodstream infectioncandidaemiainverse probability of treatment weightingmortality

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Institute for Innovation in Digital Healthcare, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Division of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon 22332, Republic of Korea.

ORCID-Profile: Mindong Sung, Shihwan Jang, Ah Young Leem, Chan Ho Lee, Kyung Soo Chung, Young Sam Kim, Joon Kim, Su Hwan Lee

Förderung

  • Korea Health Industry Development Institute
  • Severance Hospital
  • Yonsei University College of Medicine
  • Severance Hospital Research Fund for Clinical Excellence
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Sung, M., Jang, S., Leem, A. Y., Lee, C. H., Chung, K. S., Kim, Y. S., Kim, J., & Lee, S. H. (2026). Clinical Outcomes of Candida auris Versus Other Candida Species Bloodstream Infections: An IPTW-Adjusted Cohort Study in South Korea. Journal of Fungi, 12(7), 495. https://doi.org/10.3390/jof12070495

Vancouver

Sung M, Jang S, Leem AY, Lee CH, Chung KS, Kim YS, et al. Clinical Outcomes of Candida auris Versus Other Candida Species Bloodstream Infections: An IPTW-Adjusted Cohort Study in South Korea. Journal of Fungi. 2026;12(7):495. doi:10.3390/jof12070495

BibTeX
@article{Sung2026,
  author = {Sung, Mindong and Jang, Shihwan and Leem, Ah Young and Lee, Chan Ho and Chung, Kyung Soo and Kim, Young Sam and Kim, Joon and Lee, Su Hwan},
  title = {Clinical Outcomes of Candida auris Versus Other Candida Species Bloodstream Infections: An IPTW-Adjusted Cohort Study in South Korea},
  journal = {Journal of Fungi},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {495},
  doi = {10.3390/jof12070495}
}
Kostenlos starten →